Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
FDA Approval: Pembrolizumab was approved by the FDA on March 22, 2021. It is used in combination with platinum- and fluoropyrimidine-based chemotherapy (e.g., Cisplatin + Fluorouracil + Pembrolizumab) for patients with metastatic or locally advanced Esophageal cancer or gastroesophageal junction carcinoma who are not suitable for surgical resection or definitive chemoradiation (1, 2)
EMA Authorization: The EMA has authorized pembrolizumab for use with platinum- and fluoropyrimidine-based chemotherapy in esophageal cancer. The specific…